AI Article Synopsis

  • Evidence for shockwave therapy (SWT) in treating greater trochanteric pain syndrome (GTPS) is insufficient, prompting this study to evaluate its efficacy on pain and function.
  • A review of 12 studies involving 1,121 subjects found no significant differences in pain or functional outcomes between SWT and control groups, although SWT showed moderate effects on pain and low effects on function.
  • The research concludes that while SWT did not yield statistically significant improvements compared to controls, the treatment may still be a viable option due to the low occurrence of side effects and some observed clinical benefits.

Article Abstract

Background: Evidence is lacking for the efficacy of shockwave therapy (SWT) in the treatment of greater trochanteric pain syndrome (GTPS).

Aim: To investigate the efficacy of SWT on pain and function in the management of GTPS.

Methods: A systematic search of electronic databases and grey literature was conducted up to May 2023. Studies utilising SWT on adults for GTPS, providing measures of pain and/or function at baseline and at follow-up were considered for inclusion. Meta-analysis was undertaken using converted pain and functional outcomes. Studies were assessed for quality and risk of bias, and assigned a level of evidence as per the Grading of Recommendations, Assessment, Development and Evaluations criteria.

Results: Twelve articles (n = 1121 subjects) were included, including five randomised controlled trials (RCTs) and seven non-RCTs. No statistical differences were observed for pain over time f(1,5) = 1.349 (p = 0.298) or between SWT and control f(1,5) = 1.782 (p = 0.238). No significant differences in functional outcomes in short- (H = 2.591, p = 0.181) and medium-term follow-up (H = 0.189, p = 0.664) were identified between SWT and control. Moderate magnitude treatment effects for pain (Hedges-G [HG] 0.71) favouring SWT groups over control was identified, decreasing to low for function (HG 0.20). Further pain and functional treatment effects were identified at higher magnitudes across follow-up time-points in SWT groups compared to control.

Conclusion: Moderate-quality evidence demonstrated no statistically significant improvements in pain and function post-SWT compared to control. Low-quality evidence established clinical improvements throughout all included studies favouring SWT over control. Consequently, owing to relatively low incidence of side effects, SWT should be considered a viable option for the management of GTPS. Issues with both clinical and statistical heterogeneity of studies and during meta-analysis require consideration, and more robust RCTs are recommended if the efficacy of SWT for the management of GTPS is to be comprehensively determined.

Download full-text PDF

Source
http://dx.doi.org/10.1002/msc.1892DOI Listing

Publication Analysis

Top Keywords

swt control
12
swt
10
pain
9
shockwave therapy
8
greater trochanteric
8
trochanteric pain
8
efficacy swt
8
pain function
8
pain functional
8
functional outcomes
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!